Literature DB >> 11564394

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.

D P Chew1, D L Bhatt, M A Robbins, D Mukherjee, M Roffi, J P Schneider, E J Topol, S G Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11564394     DOI： 10.1016/s0002-9149(01)01813-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  16 in total

Review 1.  A guide to drug use during percutaneous coronary intervention.

Authors:  Joseph K Choo; John J Young; Dean J Kereiakes
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Antiplatelet therapies in combination for the treatment of patients with stable and unstable coronary artery disease.

Authors:  Ronnier J Aviles; Deepak L Bhatt
Journal:  J Thromb Thrombolysis       Date:  2002-06       Impact factor: 2.300

Review 3.  C-reactive protein and risk of cardiovascular disease: evidence and clinical application.

Authors:  Paul M Ridker; Shari S Bassuk; Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 4.  Measurement of thrombosis and its prevention.

Authors:  Gordon D O Lowe
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 5.  Inflammation and atherosclerosis.

Authors:  Mehdi H Shishehbor; Deepak L Bhatt
Journal:  Curr Atheroscler Rep       Date:  2004-03       Impact factor: 5.113

6.  Relation between impaired antiplatelet response to clopidogrel and possible pleiotropic effects.

Authors:  Lukasz A Malek; Marcin Grabowski; Mateusz Spiewak; Krzysztof J Filipiak; Monika Szpotanska; Tomasz Imiela; Zenon Huczek; Dagna Bobilewicz; Grzegorz Opolski
Journal:  J Thromb Thrombolysis       Date:  2007-04-03       Impact factor: 2.300

7.  Determining the efficacy of antiplatelet therapies for the individual: lessons from clinical trials.

Authors:  Steven R Steinhubl; David J Schneider; Peter B Berger; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2007-11-01       Impact factor: 2.300

Review 8.  Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists.

Authors:  Srinivas Iyengar; LeRoy E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2008-04-09       Impact factor: 2.300

Review 9.  Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.

Authors:  Nicola Ferri; Alberto Corsini; Stefano Bellosta
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

10.  Efficacy of clopidrogel on reperfusion and high-sensitivity C-reactive protein in patients with acute myocardial infarction.

Authors:  Mehmet Akbulut; Makbule Kutlu; Yilmaz Ozbay; Veli Polat; Mehmet Nail Bilen; Adil Baydas; Yakup Altas
Journal:  Mediators Inflamm       Date:  2009-04-12       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.